Quantcast

Latest hepatitis C Stories

2014-10-22 12:29:19

Boston, MA - Hynes Convention Center, November 7 - 11, 2014 ALEXANDRIA, Va. and BOSTON, Oct. 22, 2014 /PRNewswire/ -- The Liver Meeting® is the premier Annual Meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments, and the results from pilot and multicenter studies. Approximately 10 percent of Americans have some form of liver disease, but fortunately, the research community has made great strides in recent years in developing new...

2014-10-10 16:24:32

Provides use, cost forecast based on testing, future treatment rates ST. PAUL, Minn., Oct. 10, 2014 /PRNewswire/ -- Today's U.S. Food and Drug Administration (FDA) approval of Gilead's new, fixed-dose, combination Hepatitis C drug signals another spike in treatment and pharmacy costs for health plans across the country, according to Prime Therapeutics LLC (Prime). "When Sovaldi launched earlier this year, we saw a dramatic increase in prescriptions for the drug," said Peter Wickersham, senior...

2014-10-01 12:30:59

Data from 25 accepted abstracts include results from: NORTH CHICAGO, Ill., Oct. 1, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced that data from its ongoing Phase 1 through Phase 3 hepatitis C clinical development programs will be presented at The Liver Meeting®, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, November 7-11, 2014. Abstracts will be presented highlighting results from AbbVie's investigational treatment combining three...

2014-09-28 23:02:11

MarketOptimizer.org adds “PharmaPoint: Hepatitis C Virus – Global Drug Forecast and Market Analysis to 2022 – Event-Driven Update” to its store. Hepatitis C Virus Market is expected to grow during the Forecast Period. Dallas, TX (PRWEB) September 28, 2014 The Hepatitis C Virus Market generated approximately $4.2 billion from global sales in 2012. Over the next 10 years, this market is expected to grow to reach $12.8 billion, with major growth occurring in the main Hepatitis C...

2014-09-17 08:29:54

Data shows recent plateau and drop in therapy utilization, but experts suggest new surge upon pending approval of new regimens WOONSOCKET, R.I., Sept. 17, 2014 /PRNewswire/ -- An analysis done by the CVS Health Research Institute provides insights regarding patients taking Sovaldi® (sofosbuvir), a new and expensive treatment for Hepatitis C introduced in December. The data shows that over the last several months (May through August 2014) there has been a plateau and actual...

2014-09-17 08:29:05

DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Hepatitis C Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Hepatitis C is a liver disease caused by infection due to hepatitis C virus. Hepatitis C infection predominantly affects the liver; however, other parts of the body are also affected such as the brain and the digestive system. Hepatitis C virus is an RNA virus belonging to the family...

2014-09-15 23:03:41

Complimentary Hayes, Inc. webinar reviews new management options and their effects on patient outcomes. Lansdale, PA (PRWEB) September 15, 2014 For the 3.2 million people in the United States infected with the hepatitis C virus, disease management can be costly and debilitating. But are the new agents recently approved by the Food and Drug Administration (FDA) a better way to manage the disease? Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—What You Need to Know is a...

2014-09-15 08:28:17

PITTSBURGH and HYDERABAD, India, Sept. 15, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences, Inc. under which Mylan has been licensed the non-exclusive rights to manufacture and distribute sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir in 91 developing countries. Sofosbuvir is marketed by Gilead under the brand name Sovaldi®....

2014-09-11 08:28:27

NEW YORK, Sept. 11, 2014 /PRNewswire/ -- The AASLD/EASL Special Conference on Hepatitis C will discuss new therapeutic options that can cure the vast majority of patients with HCV, insights on global epidemiology, barriers to care, and potential solutions to improve global access to therapy. Members of the media interested in attending the conference may apply for a press pass by submitting their registration request and credential information to Ann Haran at aharan@aasld.org. Join us in New...

2014-08-30 23:04:47

Genomics R&D firm, Ryogen LLC, has been awarded two U.S. Patents – its 33rd and 34th – that are directed to polynucleotide sequences that play critical roles in Diabetes and Hepatitis C. Suffern, N.Y. (PRWEB) August 30, 2014 Ryogen LLC, an R&D company focusing on polynucleotide sequences implicated in human diseases, was awarded two new patents, bringing the total number of its issued U.S. Patents to 34. U.S. Patent No. 8,795,959 titled “Isolated glucokinase genomic...


Latest hepatitis C Reference Libraries

11_9e88d15808b8ecc3fcbbdfcf4ae75786
2011-01-20 19:23:30

Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...

More Articles (1 articles) »
Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin